← Back to Search

Hemostatic Agent

Bone Wax for Total Knee Arthroplasty

N/A

Waitlist Available

Led By Eugene Krauss, MD

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up blood loss is measured the morning of postoperative day 1.

Awards & highlights

Study Summary

This trial will compare the effects of bone wax on exposed cancellous bone in patients undergoing TKA. Blood loss will be measured to assess hemostasis.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ blood loss is measured the morning of postoperative day 1.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~blood loss is measured the morning of postoperative day 1.

This trial's timeline: 3 weeks for screening, Varies for treatment, and blood loss is measured the morning of postoperative day 1. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Blood Loss

Secondary outcome measures

Knee Society Scoring System

Trial Design

2Treatment groups

Active Control

Group I: Treatment armActive Control1 Intervention

This arm will have bone wax applied to the exposed cancellous surfaces of the bone.

Group II: Control ArmActive Control1 Intervention

This arm will serve as the control group. Bone wax will not be used in this group.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor

458 Previous Clinical Trials

470,881 Total Patients Enrolled

Eugene Krauss, MDPrincipal Investigator - Syosset Hospital, Northwell Health

New York Orthopedic and Spine Services, North Shore University Hospital, North Shore University Hospital at Syosset

Columbia University College Of Physicians And Surgeons (Medical School)

Hosp For Special Surg (Residency)

Media Library

Bone Wax (Hemostatic Agent) Clinical Trial Eligibility Overview. Trial Name: NCT04992052 — N/A

Total Knee Arthroplasty Research Study Groups: Treatment arm, Control Arm

Total Knee Arthroplasty Clinical Trial 2023: Bone Wax Highlights & Side Effects. Trial Name: NCT04992052 — N/A

Bone Wax (Hemostatic Agent) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04992052 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any spots available for enrollment in this research project?

"The trial, which began recruiting on July 27th 2021, is currently seeking participants. The most recent update for this study was made on October 20th 2022 according to clinicaltrials.gov."

Answered by AI

How many individuals are being enrolled in this medical experiment?

"Confirmed. According to clinicaltrials.gov, the trial opened on July 27th 2021 and was last updated on October 20th 2022; it is presently seeking 100 volunteers at a single medical centre."

Answered by AI